3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
17
Triple Negative Breast Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
rebastinib
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Paclitaxel
1
Nivolumab
1
Immunoglobulin G
1
Fluorouracil
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
X-Rays
×
Breast
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled